Chiloscyllium plagiosum isolate BGI_BamShark_2017 chromosome 42, ASM401019v2, whole genome shotgun sequence.
Chiloscyllium plagiosum (whitespotted bambooshark)
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Chondrichthyes; Elasmobranchii; Galeomorphii; Galeoidea; Orectolobiformes; Hemiscylliidae; Chiloscyllium.
REFSEQ INFORMATION: The reference sequence is identical to\nCM012997.1.\nAssembly name: ASM401019v2\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the BGI on 2019/01/10. The\noriginal whole-genome shotgun project has the accession\nQPFF00000000.1.\n\n##Genome-Assembly-Data-START##\nAssembly Provider :: BGI\nAssembly Method :: platanus v. 1.2.4; 3ddna v. 170123\nGenome Representation :: Full\nExpected Final Version :: Yes\nGenome Coverage :: 280.0x\nSequencing Technology :: BGIseq-500\n##Genome-Assembly-Data-END##\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Name :: Chiloscyllium plagiosum Annotation\n Release 100\nAnnotation Version :: 100\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 9.0\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA serine (anticodon UGA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon.
ubiquitin-conjugating enzyme E2 D4-like, transcript variant X2
COORDINATES: polyA evidence [ECO:0006239]
ubiquitin-conjugating enzyme E2 D4-like, transcript variant X1
ubiquitin-conjugating enzyme E2 D4-like, transcript variant X3
ubiquitin-conjugating enzyme E2 D4-like isoform X2
ubiquitin-conjugating enzyme E2 D4-like isoform X1
ubiquitin-conjugating enzyme E2 D4-like isoform X3
transcription factor 7-like 2, transcript variant X2
transcription factor 7-like 2, transcript variant X1
transcription factor 7-like 2 isoform X2
transcription factor 7-like 2 isoform X1
transcription factor 7-like 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
transcription factor 7-like 2 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
trans-Golgi network integral membrane protein TGN38-like, transcript variant X1
trans-Golgi network integral membrane protein TGN38-like, transcript variant X2
trans-Golgi network integral membrane protein TGN38-like isoform X1
trans-Golgi network integral membrane protein TGN38-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
cell division cycle and apoptosis regulator protein 1-like, transcript variant X2
cell division cycle and apoptosis regulator protein 1-like, transcript variant X1
cell division cycle and apoptosis regulator protein 1-like isoform X2
cell division cycle and apoptosis regulator protein 1-like isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
PDZ and LIM domain 2 (mystique), transcript variant X2
PDZ and LIM domain 2 (mystique), transcript variant X1
sorbin and SH3 domain containing 3, transcript variant X2
sorbin and SH3 domain containing 3, transcript variant X1
serine/threonine-protein phosphatase 2B catalytic subunit gamma isoform-like, transcript variant X1
serine/threonine-protein phosphatase 2B catalytic subunit gamma isoform-like, transcript variant X2
serine/threonine-protein phosphatase 2B catalytic subunit gamma isoform-like, transcript variant X4
serine/threonine-protein phosphatase 2B catalytic subunit gamma isoform-like, transcript variant X3
serine/threonine-protein phosphatase 2B catalytic subunit gamma isoform-like isoform X1
serine/threonine-protein phosphatase 2B catalytic subunit gamma isoform-like isoform X2
serine/threonine-protein phosphatase 2B catalytic subunit gamma isoform-like isoform X3
solute carrier family 39 member 14, transcript variant X6
solute carrier family 39 member 14, transcript variant X1
solute carrier family 39 member 14, transcript variant X2
solute carrier family 39 member 14, transcript variant X8
solute carrier family 39 member 14, transcript variant X5
solute carrier family 39 member 14, transcript variant X4
solute carrier family 39 member 14, transcript variant X7
solute carrier family 39 member 14, transcript variant X3
piwi-like RNA-mediated gene silencing 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
piwi-like RNA-mediated gene silencing 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 47 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
piwi-like RNA-mediated gene silencing 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins
AT-rich interactive domain-containing protein 5B-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
aspartate dehydrogenase domain containing, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
aspartate dehydrogenase domain containing, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: cmsearch.
COORDINATES: nucleotide motif:Rfam:12.0:RF00001
calcium-activated potassium channel subunit alpha-1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 92% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
pyridoxal phosphate binding protein, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
pyridoxal phosphate binding protein, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
pyridoxal phosphate homeostasis protein isoform X1
pyridoxal phosphate homeostasis protein isoform X2
adhesion G protein-coupled receptor A2-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 77% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 43 Proteins, and 61% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: fibroblast growth factor 8-like
polysaccharide biosynthesis domain containing 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
polysaccharide biosynthesis domain containing 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
polysaccharide biosynthesis domain containing 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
polysaccharide biosynthesis domain containing 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
docking protein 2-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
docking protein 2-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
GDNF family receptor alpha-2-like, transcript variant X1
GDNF family receptor alpha-2-like isoform X1
GDNF family receptor alpha-2-like, transcript variant X2
GDNF family receptor alpha-2-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
germ cell-less, spermatogenesis associated
protransforming growth factor alpha-like
aspartate aminotransferase, cytoplasmic-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
aspartate aminotransferase, cytoplasmic-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
aspartate aminotransferase, cytoplasmic-like isoform X2
aspartate aminotransferase, cytoplasmic-like isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 97 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
leucine zipper putative tumor suppressor 1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
leucine zipper putative tumor suppressor 1-like, transcript variant X1
leucine zipper putative tumor suppressor 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 31 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
phosphatidylethanolamine-binding protein 4, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
phosphatidylethanolamine-binding protein 4, transcript variant X5
phosphatidylethanolamine-binding protein 4, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
phosphatidylethanolamine-binding protein 4, transcript variant X3
phosphatidylethanolamine-binding protein 4 isoform X4
phosphatidylethanolamine-binding protein 4 isoform X1
phosphatidylethanolamine-binding protein 4 isoform X2
phosphatidylethanolamine-binding protein 4, transcript variant X4
phosphatidylethanolamine-binding protein 4 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
phosphatidylethanolamine-binding protein 4, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
phosphatidylethanolamine-binding protein 4 isoform X5
Rho related BTB domain containing 2a, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
Rho related BTB domain containing 2a, transcript variant X1
Rho related BTB domain containing 2a, transcript variant X2
rho-related BTB domain-containing protein 2 isoform X1
rho-related BTB domain-containing protein 2 isoform X3
Rho related BTB domain containing 2a, transcript variant X3
rho-related BTB domain-containing protein 2 isoform X2
Rho related BTB domain containing 2a, transcript variant X5
Rho related BTB domain containing 2a, transcript variant X6
rho-related BTB domain-containing protein 2 isoform X4
eukaryotic translation initiation factor 4E-binding protein 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
set1/Ash2 histone methyltransferase complex subunit ASH2-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 45 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
steroidogenic acute regulatory protein, mitochondrial
phospholipid phosphatase 4-like, transcript variant X3
phospholipid phosphatase 4-like, transcript variant X1
phospholipid phosphatase 4-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
DDHD domain containing 2, transcript variant X2
DDHD domain containing 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
zinc metalloproteinase-disintegrin-like crotastatin, transcript variant X3
zinc metalloproteinase-disintegrin-like crotastatin, transcript variant X2
zinc metalloproteinase-disintegrin-like crotastatin, transcript variant X1
zinc metalloproteinase-disintegrin-like crotastatin isoform X3
zinc metalloproteinase-disintegrin-like crotastatin isoform X2
zinc metalloproteinase-disintegrin-like crotastatin isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 36 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
mitoferrin-1-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
mitoferrin-1-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
mitoferrin-1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
mitoferrin-1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 37 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 90% coverage of the annotated genomic feature by RNAseq alignments
R3H and coiled-coil domain-containing protein 1
ectonucleoside triphosphate diphosphohydrolase 4, transcript variant X3
ectonucleoside triphosphate diphosphohydrolase 4, transcript variant X1
ectonucleoside triphosphate diphosphohydrolase 4, transcript variant X2
ectonucleoside triphosphate diphosphohydrolase 4 isoform X2
ectonucleoside triphosphate diphosphohydrolase 4 isoform X1
ectonucleoside triphosphate diphosphohydrolase 4 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
ras association domain-containing protein 2a
uncharacterized LOC122543229, transcript variant X2
uncharacterized protein LOC122543229 isoform X2
uncharacterized LOC122543229, transcript variant X1
uncharacterized protein LOC122543229 isoform X1
beta-microseminoprotein-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
beta-microseminoprotein-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 36 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
anthrax toxin receptor 1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
anthrax toxin receptor 1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
anthrax toxin receptor 1-like isoform X1
anthrax toxin receptor 1-like isoform X2
glutamine--fructose-6-phosphate transaminase 1, transcript variant X3
glutamine--fructose-6-phosphate transaminase 1, transcript variant X2
glutamine--fructose-6-phosphate transaminase 1, transcript variant X1
glutamine--fructose-6-phosphate aminotransferase [isomerizing] 1 isoform X3
glutamine--fructose-6-phosphate aminotransferase [isomerizing] 1 isoform X2
glutamine--fructose-6-phosphate aminotransferase [isomerizing] 1 isoform X1
NFU1 iron-sulfur cluster scaffold homolog, mitochondrial-like, transcript variant X2
NFU1 iron-sulfur cluster scaffold homolog, mitochondrial-like, transcript variant X1
NFU1 iron-sulfur cluster scaffold homolog, mitochondrial-like isoform X2
NFU1 iron-sulfur cluster scaffold homolog, mitochondrial-like isoform X1
AP2 associated kinase 1b, transcript variant X4
AP2 associated kinase 1b, transcript variant X2
AP2 associated kinase 1b, transcript variant X1
AP2 associated kinase 1b, transcript variant X3
AP2-associated protein kinase 1 isoform X4
AP2-associated protein kinase 1 isoform X3
AP2-associated protein kinase 1 isoform X2
AP2-associated protein kinase 1 isoform X1
AP2 associated kinase 1b, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
AP2 associated kinase 1b, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
AP2 associated kinase 1b, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
AP2-associated protein kinase 1 isoform X7
AP2-associated protein kinase 1 isoform X6
AP2-associated protein kinase 1 isoform X5
uncharacterized LOC122543060, transcript variant X2
uncharacterized LOC122543060, transcript variant X1
pituitary homeobox 3-like, transcript variant X3
pituitary homeobox 3-like, transcript variant X2
pituitary homeobox 3-like, transcript variant X1
pituitary homeobox 3-like, transcript variant X4
uncharacterized LOC122543061, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized LOC122543061, transcript variant X2
netrin receptor UNC5D-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
netrin receptor UNC5D-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
transfer RNA asparagine (anticodon GUU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
cytoplasmic polyadenylation element-binding protein 2-like, transcript variant X2
cytoplasmic polyadenylation element-binding protein 2-like, transcript variant X1
cytoplasmic polyadenylation element-binding protein 2-like
E3 ubiquitin-protein ligase MARCHF5-like
uncharacterized LOC122543068, transcript variant X1
uncharacterized LOC122543068, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4C, transcript variant X4
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4C, transcript variant X10
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4C, transcript variant X5
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4C, transcript variant X11
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4C, transcript variant X1
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4C, transcript variant X2
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4C, transcript variant X6
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4C, transcript variant X12
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4C, transcript variant X3
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4C, transcript variant X8
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4C, transcript variant X7
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4C, transcript variant X9
receptor expression-enhancing protein 1-like, transcript variant X2
receptor expression-enhancing protein 1-like, transcript variant X1
receptor expression-enhancing protein 1-like isoform X2
receptor expression-enhancing protein 1-like isoform X1
uncharacterized LOC122543232, transcript variant X1
uncharacterized LOC122543232, transcript variant X2
leucine-rich repeat transmembrane neuronal protein 4-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 59 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
dihydropyrimidinase-related protein 2, transcript variant X2
dihydropyrimidinase-related protein 2, transcript variant X1
dihydropyrimidinase-related protein 2 isoform X2
dihydropyrimidinase-related protein 2 isoform X1
BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like
serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B alpha isoform, transcript variant X2
serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B alpha isoform, transcript variant X1
serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B alpha isoform isoform X2
serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B alpha isoform isoform X1
transcription factor COE2, transcript variant X2
transcription factor COE2, transcript variant X3
transcription factor COE2, transcript variant X5
transcription factor COE2, transcript variant X4
transcription factor COE2, transcript variant X1
uncharacterized LOC122543077, transcript variant X4
uncharacterized LOC122543077, transcript variant X3
uncharacterized LOC122543077, transcript variant X2
uncharacterized LOC122543077, transcript variant X1
uncharacterized LOC122543077, transcript variant X5
uncharacterized protein LOC122543077 isoform X2
uncharacterized protein LOC122543077 isoform X1
probable ATP-dependent RNA helicase DDX56
transmembrane emp24 domain-containing protein 4-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
cytosolic purine 5'-nucleotidase-like, transcript variant X3
cytosolic purine 5'-nucleotidase-like isoform X3
cytosolic purine 5'-nucleotidase-like, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
cytosolic purine 5'-nucleotidase-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 35 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
cytosolic purine 5'-nucleotidase-like isoform X5
cytosolic purine 5'-nucleotidase-like, transcript variant X12
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
cytosolic purine 5'-nucleotidase-like, transcript variant X14
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
cytosolic purine 5'-nucleotidase-like, transcript variant X15
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
cytosolic purine 5'-nucleotidase-like, transcript variant X13
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
cytosolic purine 5'-nucleotidase-like, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
cytosolic purine 5'-nucleotidase-like, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
cytosolic purine 5'-nucleotidase-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 34 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
cytosolic purine 5'-nucleotidase-like, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 34 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
cytosolic purine 5'-nucleotidase-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
cytosolic purine 5'-nucleotidase-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 35 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
cytosolic purine 5'-nucleotidase-like, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 34 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
cytosolic purine 5'-nucleotidase-like isoform X2
cytosolic purine 5'-nucleotidase-like isoform X7
cytosolic purine 5'-nucleotidase-like isoform X4
cytosolic purine 5'-nucleotidase-like isoform X8
cytosolic purine 5'-nucleotidase-like isoform X1
cytosolic purine 5'-nucleotidase-like isoform X6
cytosolic purine 5'-nucleotidase-like isoform X9
cytosolic purine 5'-nucleotidase-like isoform X11
cytosolic purine 5'-nucleotidase-like isoform X12
cytosolic purine 5'-nucleotidase-like isoform X13
cytosolic purine 5'-nucleotidase-like, transcript variant X11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
cytosolic purine 5'-nucleotidase-like isoform X10
sodium-dependent phosphate transporter 1-like
small nuclear ribonucleoprotein 200 (U5), transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
small nuclear ribonucleoprotein 200 (U5), transcript variant X1
U5 small nuclear ribonucleoprotein 200 kDa helicase isoform X1
U5 small nuclear ribonucleoprotein 200 kDa helicase isoform X2
cytosolic iron-sulfur assembly component 1
probable cytosolic iron-sulfur protein assembly protein ciao1
non-SMC condensin I complex, subunit H, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
non-SMC condensin I complex, subunit H, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
inositol 1,4,5-trisphosphate receptor-interacting protein-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
ring finger protein 122, transcript variant X3
ring finger protein 122, transcript variant X2
ring finger protein 122, transcript variant X1
ring finger protein 122, transcript variant X4
COORDINATES: nucleotide motif:Rfam:12.0:RF01210
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
V-type proton ATPase subunit B, brain isoform
glucokinase (hexokinase 4), transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
glucokinase (hexokinase 4), transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 66 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
glucokinase (hexokinase 4), transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
myosin regulatory light chain 2, atrial isoform
polymerase (DNA directed), delta 2, regulatory subunit
inactive carboxypeptidase-like protein X2, transcript variant X2
inactive carboxypeptidase-like protein X2, transcript variant X1
inactive carboxypeptidase-like protein X2
ELMO/CED-12 domain containing 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
ELMO/CED-12 domain containing 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
ELMO/CED-12 domain containing 3, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
ELMO/CED-12 domain containing 3, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
ELMO domain-containing protein 3 isoform X1
ELMO domain-containing protein 3 isoform X3
ELMO domain-containing protein 3 isoform X2
glycerol-3-phosphate acyltransferase 1, mitochondrial-like, transcript variant X3
glycerol-3-phosphate acyltransferase 1, mitochondrial-like, transcript variant X4
glycerol-3-phosphate acyltransferase 1, mitochondrial-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
glycerol-3-phosphate acyltransferase 1, mitochondrial-like, transcript variant X7
glycerol-3-phosphate acyltransferase 1, mitochondrial-like, transcript variant X1
glycerol-3-phosphate acyltransferase 1, mitochondrial-like, transcript variant X2
glycerol-3-phosphate acyltransferase 1, mitochondrial-like, transcript variant X6
glycerol-3-phosphate acyltransferase 1, mitochondrial-like isoform X1
glycerol-3-phosphate acyltransferase 1, mitochondrial-like isoform X2
glycerol-3-phosphate acyltransferase 1, mitochondrial-like isoform X4
glycerol-3-phosphate acyltransferase 1, mitochondrial-like isoform X5
glycerol-3-phosphate acyltransferase 1, mitochondrial-like isoform X3
fumarylacetoacetate hydrolase domain containing 2A, transcript variant X4
fumarylacetoacetate hydrolase domain containing 2A, transcript variant X2
fumarylacetoacetate hydrolase domain containing 2A, transcript variant X6
fumarylacetoacetate hydrolase domain containing 2A, transcript variant X3
fumarylacetoacetate hydrolase domain containing 2A, transcript variant X5
fumarylacetoacetate hydrolase domain containing 2A, transcript variant X1
fumarylacetoacetate hydrolase domain-containing protein 2A isoform X2
fumarylacetoacetate hydrolase domain-containing protein 2A isoform X1
fumarylacetoacetate hydrolase domain-containing protein 2A isoform X3
uncharacterized protein LOC767682 homolog
polymerase (DNA directed), mu, transcript variant X1
DNA-directed DNA/RNA polymerase mu isoform X1
lysoplasmalogenase-like protein TMEM86A, transcript variant X1
lysoplasmalogenase-like protein TMEM86A, transcript variant X2
lysoplasmalogenase-like protein TMEM86A isoform X1
lysoplasmalogenase-like protein TMEM86A isoform X2
B-cell linker protein-like, transcript variant X3
B-cell linker protein-like, transcript variant X1
B-cell linker protein-like, transcript variant X2
B-cell linker protein-like, transcript variant X4
transfer RNA lysine (anticodon CUU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
glucosamine (N-acetyl)-6-sulfatase (Sanfilippo disease IIID), b
polymerase (DNA directed), mu, transcript variant X4
polymerase (DNA directed), mu, transcript variant X2
DNA-directed DNA/RNA polymerase mu isoform X2
polymerase (DNA directed), mu, transcript variant X3
polymerase (DNA directed), mu, transcript variant X5
DNA-directed DNA/RNA polymerase mu isoform X3
calcium/calmodulin-dependent protein kinase type II subunit beta, transcript variant X1
calcium/calmodulin-dependent protein kinase type II subunit beta, transcript variant X4
calcium/calmodulin-dependent protein kinase type II subunit beta, transcript variant X2
calcium/calmodulin-dependent protein kinase type II subunit beta, transcript variant X12
calcium/calmodulin-dependent protein kinase type II subunit beta, transcript variant X3
calcium/calmodulin-dependent protein kinase type II subunit beta, transcript variant X5
calcium/calmodulin-dependent protein kinase type II subunit beta, transcript variant X9
calcium/calmodulin-dependent protein kinase type II subunit beta, transcript variant X15
calcium/calmodulin-dependent protein kinase type II subunit beta, transcript variant X6
calcium/calmodulin-dependent protein kinase type II subunit beta, transcript variant X11
calcium/calmodulin-dependent protein kinase type II subunit beta, transcript variant X18
calcium/calmodulin-dependent protein kinase type II subunit beta, transcript variant X19
calcium/calmodulin-dependent protein kinase type II subunit beta, transcript variant X7
calcium/calmodulin-dependent protein kinase type II subunit beta, transcript variant X8
calcium/calmodulin-dependent protein kinase type II subunit beta, transcript variant X23
calcium/calmodulin-dependent protein kinase type II subunit beta, transcript variant X25
calcium/calmodulin-dependent protein kinase type II subunit beta, transcript variant X13
calcium/calmodulin-dependent protein kinase type II subunit beta, transcript variant X14
calcium/calmodulin-dependent protein kinase type II subunit beta, transcript variant X10
calcium/calmodulin-dependent protein kinase type II subunit beta, transcript variant X16
calcium/calmodulin-dependent protein kinase type II subunit beta, transcript variant X29
calcium/calmodulin-dependent protein kinase type II subunit beta, transcript variant X17
calcium/calmodulin-dependent protein kinase type II subunit beta, transcript variant X20
calcium/calmodulin-dependent protein kinase type II subunit beta, transcript variant X24
calcium/calmodulin-dependent protein kinase type II subunit beta, transcript variant X33
calcium/calmodulin-dependent protein kinase type II subunit beta, transcript variant X22
calcium/calmodulin-dependent protein kinase type II subunit beta, transcript variant X21
calcium/calmodulin-dependent protein kinase type II subunit beta, transcript variant X27
calcium/calmodulin-dependent protein kinase type II subunit beta, transcript variant X26
calcium/calmodulin-dependent protein kinase type II subunit beta, transcript variant X31
calcium/calmodulin-dependent protein kinase type II subunit beta, transcript variant X28
calcium/calmodulin-dependent protein kinase type II subunit beta, transcript variant X30
calcium/calmodulin-dependent protein kinase type II subunit beta, transcript variant X32
calcium/calmodulin-dependent protein kinase type II subunit beta, transcript variant X34
calcium/calmodulin-dependent protein kinase type II subunit beta, transcript variant X35
calcium/calmodulin-dependent protein kinase type II subunit beta, transcript variant X50
calcium/calmodulin-dependent protein kinase type II subunit beta, transcript variant X38
calcium/calmodulin-dependent protein kinase type II subunit beta, transcript variant X36
calcium/calmodulin-dependent protein kinase type II subunit beta, transcript variant X41
calcium/calmodulin-dependent protein kinase type II subunit beta, transcript variant X37
calcium/calmodulin-dependent protein kinase type II subunit beta, transcript variant X44
calcium/calmodulin-dependent protein kinase type II subunit beta, transcript variant X39
calcium/calmodulin-dependent protein kinase type II subunit beta, transcript variant X40
calcium/calmodulin-dependent protein kinase type II subunit beta, transcript variant X47
calcium/calmodulin-dependent protein kinase type II subunit beta, transcript variant X42
calcium/calmodulin-dependent protein kinase type II subunit beta, transcript variant X45
calcium/calmodulin-dependent protein kinase type II subunit beta, transcript variant X43
calcium/calmodulin-dependent protein kinase type II subunit beta, transcript variant X48
calcium/calmodulin-dependent protein kinase type II subunit beta, transcript variant X46
calcium/calmodulin-dependent protein kinase type II subunit beta, transcript variant X49
calcium/calmodulin-dependent protein kinase type II subunit beta isoform X1
calcium/calmodulin-dependent protein kinase type II subunit beta isoform X4
calcium/calmodulin-dependent protein kinase type II subunit beta isoform X9
calcium/calmodulin-dependent protein kinase type II subunit beta isoform X18
calcium/calmodulin-dependent protein kinase type II subunit beta isoform X38
calcium/calmodulin-dependent protein kinase type II subunit beta isoform X15
calcium/calmodulin-dependent protein kinase type II subunit beta isoform X50
calcium/calmodulin-dependent protein kinase type II subunit beta isoform X23
calcium/calmodulin-dependent protein kinase type II subunit gamma isoform X12
calcium/calmodulin-dependent protein kinase type II subunit beta isoform X19
calcium/calmodulin-dependent protein kinase type II subunit delta isoform X29
calcium/calmodulin-dependent protein kinase type II subunit beta isoform X44
calcium/calmodulin-dependent protein kinase type II subunit beta isoform X25
calcium/calmodulin-dependent protein kinase type II subunit beta isoform X41
calcium/calmodulin-dependent protein kinase type II delta chain isoform X33
calcium/calmodulin-dependent protein kinase type II subunit beta isoform X47
calcium/calmodulin-dependent protein kinase type II subunit beta isoform X2
calcium/calmodulin-dependent protein kinase type II subunit beta isoform X6
calcium/calmodulin-dependent protein kinase type II subunit beta isoform X3
calcium/calmodulin-dependent protein kinase type II subunit beta isoform X7
calcium/calmodulin-dependent protein kinase type II subunit beta isoform X17
calcium/calmodulin-dependent protein kinase type II subunit delta isoform X22
calcium/calmodulin-dependent protein kinase type II subunit beta isoform X13
calcium/calmodulin-dependent protein kinase type II subunit beta isoform X21
calcium/calmodulin-dependent protein kinase type II delta chain isoform X28
calcium/calmodulin-dependent protein kinase type II subunit beta isoform X8
calcium/calmodulin-dependent protein kinase type II subunit beta isoform X14
calcium/calmodulin-dependent protein kinase type II subunit beta isoform X36
calcium/calmodulin-dependent protein kinase type II delta chain isoform X30
calcium/calmodulin-dependent protein kinase type II subunit beta isoform X5
calcium/calmodulin-dependent protein kinase type II subunit beta isoform X10
calcium/calmodulin-dependent protein kinase type II subunit beta isoform X20
calcium/calmodulin-dependent protein kinase type II subunit delta isoform X27
calcium/calmodulin-dependent protein kinase type II subunit beta isoform X16
calcium/calmodulin-dependent protein kinase type II subunit beta isoform X37
calcium/calmodulin-dependent protein kinase type II subunit beta isoform X39
calcium/calmodulin-dependent protein kinase type II subunit beta isoform X26
calcium/calmodulin-dependent protein kinase type II subunit beta isoform X42
calcium/calmodulin-dependent protein kinase type II delta chain isoform X32
calcium/calmodulin-dependent protein kinase type II subunit beta isoform X11
calcium/calmodulin-dependent protein kinase type II subunit beta isoform X43
calcium/calmodulin-dependent protein kinase type II delta chain isoform X34
calcium/calmodulin-dependent protein kinase type II subunit beta isoform X48
calcium/calmodulin-dependent protein kinase type II subunit beta isoform X24
calcium/calmodulin-dependent protein kinase type II subunit beta isoform X40
calcium/calmodulin-dependent protein kinase type II delta chain isoform X31
calcium/calmodulin-dependent protein kinase type II subunit beta isoform X45
calcium/calmodulin-dependent protein kinase type II subunit beta isoform X46
calcium/calmodulin-dependent protein kinase type II delta chain isoform X35
calcium/calmodulin-dependent protein kinase type II subunit beta isoform X49
28S ribosomal protein S24, mitochondrial
nuclear receptor binding SET domain protein 3, transcript variant X3
nuclear receptor binding SET domain protein 3, transcript variant X4
nuclear receptor binding SET domain protein 3, transcript variant X1
nuclear receptor binding SET domain protein 3, transcript variant X2
histone-lysine N-methyltransferase NSD3 isoform X2
histone-lysine N-methyltransferase NSD3 isoform X3
histone-lysine N-methyltransferase NSD3 isoform X1
leucine zipper-EF-hand containing transmembrane protein 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
leucine zipper-EF-hand containing transmembrane protein 2, transcript variant X3
leucine zipper-EF-hand containing transmembrane protein 2, transcript variant X2
leucine zipper-EF-hand containing transmembrane protein 2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
leucine zipper-EF-hand containing transmembrane protein 2, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
LETM1 domain-containing protein LETM2, mitochondrial isoform X1
leucine zipper-EF-hand containing transmembrane protein 2, transcript variant X5
LETM1 domain-containing protein LETM2, mitochondrial isoform X3
LETM1 domain-containing protein LETM2, mitochondrial isoform X2
fibroblast growth factor receptor 1-like, transcript variant X1
fibroblast growth factor receptor 1-like, transcript variant X2
fibroblast growth factor receptor 1-like
transforming, acidic coiled-coil containing protein 1, transcript variant X5
transforming, acidic coiled-coil containing protein 1, transcript variant X4
transforming acidic coiled-coil-containing protein 1 isoform X4
transforming, acidic coiled-coil containing protein 1, transcript variant X1
transforming, acidic coiled-coil containing protein 1, transcript variant X2
transforming, acidic coiled-coil containing protein 1, transcript variant X3
transforming acidic coiled-coil-containing protein 1 isoform X1
transforming acidic coiled-coil-containing protein 1 isoform X3
transforming acidic coiled-coil-containing protein 1 isoform X2
transforming acidic coiled-coil-containing protein 1 isoform X5
pleckstrin homology domain-containing family A member 2-like
disintegrin and metalloproteinase domain-containing protein 9-like, transcript variant X4
disintegrin and metalloproteinase domain-containing protein 9-like, transcript variant X1
disintegrin and metalloproteinase domain-containing protein 9-like, transcript variant X2
disintegrin and metalloproteinase domain-containing protein 9-like, transcript variant X3
disintegrin and metalloproteinase domain-containing protein 9-like isoform X1
disintegrin and metalloproteinase domain-containing protein 9-like isoform X2
disintegrin and metalloproteinase domain-containing protein 9-like isoform X3
indoleamine 2,3-dioxygenase 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
indoleamine 2,3-dioxygenase 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
indoleamine 2,3-dioxygenase 1 isoform X1
indoleamine 2,3-dioxygenase 1 isoform X2
transcriptional and immune response regulator-like
zinc finger matrin-type protein 4-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
zinc finger matrin-type protein 4-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
zinc finger matrin-type protein 4-like, transcript variant X3
zinc finger matrin-type protein 4-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
zinc finger matrin-type protein 4-like isoform X2
zinc finger matrin-type protein 4-like isoform X1
zinc finger matrin-type protein 4-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
zinc finger matrin-type protein 4-like isoform X3
zinc finger matrin-type protein 4-like, transcript variant X6
zinc finger matrin-type protein 4-like isoform X4
zinc finger matrin-type protein 4-like, transcript variant X7
zinc finger matrin-type protein 4-like isoform X5
uncharacterized LOC122543135, transcript variant X1
uncharacterized LOC122543135, transcript variant X3
uncharacterized LOC122543135, transcript variant X4
uncharacterized LOC122543135, transcript variant X2
secreted frizzled-related protein 1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
secreted frizzled-related protein 1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
secreted frizzled-related protein 1-like isoform X2
secreted frizzled-related protein 1-like isoform X1
deleted in malignant brain tumors 1 protein-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 92% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 31 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized protein LOC550500 homolog, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
uncharacterized protein LOC550500 homolog, transcript variant X3
uncharacterized protein LOC550500 homolog, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
uncharacterized protein LOC550500 homolog, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized protein LOC550500 homolog, transcript variant X4
electrogenic sodium bicarbonate cotransporter 4-like, transcript variant X1
electrogenic sodium bicarbonate cotransporter 4-like, transcript variant X5
electrogenic sodium bicarbonate cotransporter 4-like, transcript variant X6
electrogenic sodium bicarbonate cotransporter 4-like, transcript variant X2
electrogenic sodium bicarbonate cotransporter 4-like, transcript variant X3
electrogenic sodium bicarbonate cotransporter 4-like, transcript variant X13
electrogenic sodium bicarbonate cotransporter 4-like, transcript variant X10
electrogenic sodium bicarbonate cotransporter 4-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 30 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
electrogenic sodium bicarbonate cotransporter 4-like, transcript variant X7
electrogenic sodium bicarbonate cotransporter 4-like, transcript variant X12
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 49 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
electrogenic sodium bicarbonate cotransporter 4-like isoform X1
electrogenic sodium bicarbonate cotransporter 4-like isoform X5
electrogenic sodium bicarbonate cotransporter 4-like isoform X6
electrogenic sodium bicarbonate cotransporter 4-like isoform X2
electrogenic sodium bicarbonate cotransporter 4-like isoform X3
electrogenic sodium bicarbonate cotransporter 4-like isoform X13
electrogenic sodium bicarbonate cotransporter 4-like isoform X4
electrogenic sodium bicarbonate cotransporter 4-like isoform X7
electrogenic sodium bicarbonate cotransporter 4-like isoform X12
electrogenic sodium bicarbonate cotransporter 4-like isoform X10
electrogenic sodium bicarbonate cotransporter 4-like, transcript variant X8
electrogenic sodium bicarbonate cotransporter 4-like isoform X8
electrogenic sodium bicarbonate cotransporter 4-like, transcript variant X11
electrogenic sodium bicarbonate cotransporter 4-like, transcript variant X9
electrogenic sodium bicarbonate cotransporter 4-like isoform X9
electrogenic sodium bicarbonate cotransporter 4-like isoform X11
bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial-like isoform X2
bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial-like, transcript variant X1
bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial-like isoform X1
heterogeneous nuclear ribonucleoprotein H3-like, transcript variant X3
heterogeneous nuclear ribonucleoprotein H3-like, transcript variant X2
heterogeneous nuclear ribonucleoprotein H3-like, transcript variant X1
heterogeneous nuclear ribonucleoprotein H3-like isoform X1
heterogeneous nuclear ribonucleoprotein H3-like isoform X2
tet methylcytosine dioxygenase 3, transcript variant X1
tet methylcytosine dioxygenase 3, transcript variant X5
tet methylcytosine dioxygenase 3, transcript variant X2
tet methylcytosine dioxygenase 3, transcript variant X3
tet methylcytosine dioxygenase 3, transcript variant X6
tet methylcytosine dioxygenase 3, transcript variant X7
tet methylcytosine dioxygenase 3, transcript variant X4
methylcytosine dioxygenase TET3 isoform X1
methylcytosine dioxygenase TET3 isoform X2
deoxycytidine kinase 2-like, transcript variant X8
deoxycytidine kinase 2-like, transcript variant X2
deoxycytidine kinase 2-like, transcript variant X9
deoxycytidine kinase 2-like, transcript variant X1
deoxycytidine kinase 2-like, transcript variant X5
deoxycytidine kinase 2-like, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
deoxycytidine kinase 2-like, transcript variant X3
deoxycytidine kinase 2-like, transcript variant X4
deoxycytidine kinase 2-like, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
uncharacterized protein LOC122543154 isoform X4
BCL2 associated athanogene 4, transcript variant X2
BAG family molecular chaperone regulator 4 isoform X2
BCL2 associated athanogene 4, transcript variant X1
BAG family molecular chaperone regulator 4 isoform X1
phosphatidylinositide phosphatase SAC2-like
dematin actin binding protein, transcript variant X1
dematin actin binding protein, transcript variant X3
dematin actin binding protein, transcript variant X4
dematin actin binding protein, transcript variant X2
actin filament-associated protein 1-like 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 98% coverage of the annotated genomic feature by RNAseq alignments
FHF complex subunit HOOK interacting protein 2A-like
transcription factor IIIB 50 kDa subunit-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
transcription factor IIIB 50 kDa subunit-like, transcript variant X5
transcription factor IIIB 50 kDa subunit-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
transcription factor IIIB 50 kDa subunit-like, transcript variant X1
transcription factor IIIB 50 kDa subunit-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
transcription factor IIIB 50 kDa subunit-like isoform X2
transcription factor IIIB 50 kDa subunit-like isoform X1
transcription factor IIIB 50 kDa subunit-like isoform X3
STAM-binding protein-like, transcript variant X2
STAM-binding protein-like, transcript variant X1
STAM-binding protein-like, transcript variant X4
STAM-binding protein-like, transcript variant X3
tumor necrosis factor receptor superfamily member 1A-like
GINS complex subunit 4 (Sld5 homolog), transcript variant X2
GINS complex subunit 4 (Sld5 homolog), transcript variant X1
DNA replication complex GINS protein SLD5 isoform X1
DNA replication complex GINS protein SLD5 isoform X2
charged multivesicular body protein 7, transcript variant X5
charged multivesicular body protein 7, transcript variant X6
charged multivesicular body protein 7, transcript variant X4
charged multivesicular body protein 7, transcript variant X1
charged multivesicular body protein 7, transcript variant X2
charged multivesicular body protein 7, transcript variant X3
charged multivesicular body protein 7 isoform X2
charged multivesicular body protein 7 isoform X3
charged multivesicular body protein 7 isoform X1
leucine-rich repeat LGI family, member 3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 40 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments
protein phosphatase 1 regulatory subunit 3C-like
plasminogen activator, tissue, transcript variant X2
plasminogen activator, tissue, transcript variant X3
plasminogen activator, tissue, transcript variant X1
tissue-type plasminogen activator isoform X2
tissue-type plasminogen activator isoform X1
inhibitor of nuclear factor kappa B kinase subunit beta, transcript variant X2
inhibitor of nuclear factor kappa B kinase subunit beta, transcript variant X3
inhibitor of nuclear factor kappa B kinase subunit beta, transcript variant X1
inhibitor of nuclear factor kappa B kinase subunit beta, transcript variant X4
inhibitor of nuclear factor kappa-B kinase subunit beta isoform X1
inhibitor of nuclear factor kappa-B kinase subunit beta isoform X2
group 10 secretory phospholipase A2-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 97% coverage of the annotated genomic feature by RNAseq alignments
enkurin domain containing 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
enkurin domain-containing protein 1 isoform X1
enkurin domain containing 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
enkurin domain-containing protein 1 isoform X2
polymerase (DNA directed), beta, transcript variant X2
polymerase (DNA directed), beta, transcript variant X3
polymerase (DNA directed), beta, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
polymerase (DNA directed), beta, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 55% coverage of the annotated genomic feature by RNAseq alignments
voltage-dependent anion channel 3, transcript variant X1
voltage-dependent anion-selective channel protein 3 isoform X1
voltage-dependent anion channel 3, transcript variant X2
voltage-dependent anion channel 3, transcript variant X4
voltage-dependent anion channel 3, transcript variant X3
voltage-dependent anion channel 3, transcript variant X5
voltage-dependent anion channel 3, transcript variant X6
voltage-dependent anion-selective channel protein 3 isoform X2
voltage-dependent anion-selective channel protein 3 isoform X3
voltage-dependent anion-selective channel protein 3 isoform X4
cGMP-dependent protein kinase 1-like, transcript variant X2
cGMP-dependent protein kinase 1-like, transcript variant X1
cGMP-dependent protein kinase 1-like, transcript variant X3
cGMP-dependent protein kinase 1-like isoform X2
cGMP-dependent protein kinase 1-like isoform X1
cGMP-dependent protein kinase 1-like isoform X3
outer mitochondrial transmembrane helix translocase-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
outer mitochondrial transmembrane helix translocase-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
outer mitochondrial transmembrane helix translocase-like, transcript variant X1
outer mitochondrial transmembrane helix translocase-like isoform X2
outer mitochondrial transmembrane helix translocase-like isoform X1
outer mitochondrial transmembrane helix translocase-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins
polymerase (RNA) III (DNA directed) polypeptide D
DNA-directed RNA polymerase III subunit RPC4
phytanoyl-CoA hydroxylase-interacting protein-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
phytanoyl-CoA hydroxylase-interacting protein-like, transcript variant X1
phytanoyl-CoA hydroxylase-interacting protein-like
metal transporter CNNM3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 50 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
metal transporter CNNM3, transcript variant X1
metal transporter CNNM2-like, transcript variant X2
metal transporter CNNM2-like, transcript variant X1
VIP36-like protein, transcript variant X1
VIP36-like protein, transcript variant X2
ankyrin repeat domain-containing protein 39
chromosome 42 C2orf42 homolog, transcript variant X4
chromosome 42 C2orf42 homolog, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
chromosome 42 C2orf42 homolog, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
chromosome 42 C2orf42 homolog, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
TIA1 cytotoxic granule-associated RNA binding protein, transcript variant X4
TIA1 cytotoxic granule-associated RNA binding protein, transcript variant X1
TIA1 cytotoxic granule-associated RNA binding protein, transcript variant X3
TIA1 cytotoxic granule-associated RNA binding protein, transcript variant X5
TIA1 cytotoxic granule-associated RNA binding protein, transcript variant X2
transfer RNA glycine (anticodon CCC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
family with sequence similarity 136 member A, transcript variant X2
family with sequence similarity 136 member A, transcript variant X1
prolactin-releasing peptide receptor-like
BTB/POZ domain-containing protein KCTD9-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 69% coverage of the annotated genomic feature by RNAseq alignments
progonadoliberin-1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
progonadoliberin-1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
dedicator of cytokinesis protein 5-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
dedicator of cytokinesis protein 5-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
dedicator of cytokinesis protein 5-like isoform X2
dedicator of cytokinesis protein 5-like isoform X1
dedicator of cytokinesis protein 5-like, transcript variant X3
dedicator of cytokinesis protein 5-like isoform X3
dual specificity protein phosphatase 1-A-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
NPC1-like intracellular cholesterol transporter 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 76% coverage of the annotated genomic feature by RNAseq alignments
stAR-related lipid transfer protein 7, mitochondrial-like
uncharacterized LOC122543189, transcript variant X4
uncharacterized LOC122543189, transcript variant X7
uncharacterized LOC122543189, transcript variant X1
uncharacterized LOC122543189, transcript variant X6
uncharacterized LOC122543189, transcript variant X10
uncharacterized LOC122543189, transcript variant X2
uncharacterized LOC122543189, transcript variant X3
uncharacterized LOC122543189, transcript variant X5
uncharacterized LOC122543189, transcript variant X9
COORDINATES: nucleotide motif:Rfam:12.0:RF00599
uncharacterized LOC122543189, transcript variant X8
2-oxoglutarate dehydrogenase, mitochondrial-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
2-oxoglutarate dehydrogenase, mitochondrial-like, transcript variant X1
2-oxoglutarate dehydrogenase, mitochondrial-like, transcript variant X3
2-oxoglutarate dehydrogenase, mitochondrial-like
zinc finger MIZ domain-containing protein 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
peptidyl-prolyl cis-trans isomerase CYP19-3-like, transcript variant X1
peptidyl-prolyl cis-trans isomerase CYP19-3-like, transcript variant X2
peptidyl-prolyl cis-trans isomerase CYP19-3-like isoform X1
peptidyl-prolyl cis-trans isomerase CYP19-3-like isoform X2
transmembrane protein 150A-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
transmembrane protein 150A-like, transcript variant X1
uncharacterized protein LOC122543193 isoform X2
transmembrane protein 150A-like isoform X1
transmembrane protein 150A-like, transcript variant X3
transmembrane protein 150A-like isoform X3
transmembrane protein 150A-like, transcript variant X4
transmembrane protein 150A-like isoform X4
transmembrane protein 150A-like, transcript variant X5
transmembrane protein 150A-like isoform X5
vesicle-associated membrane protein 3-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
vesicle-associated membrane protein 3-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
vesicle-associated membrane protein 3-like isoform X1
vesicle-associated membrane protein 3-like isoform X2
vitamin K-dependent gamma-carboxylase-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
vitamin K-dependent gamma-carboxylase-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 2 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
vitamin K-dependent gamma-carboxylase-like isoform X1
vitamin K-dependent gamma-carboxylase-like isoform X2
chromosome 42 C2orf68 homolog, transcript variant X1
chromosome 42 C2orf68 homolog, transcript variant X3
chromosome 42 C2orf68 homolog, transcript variant X2
UPF0561 protein C2orf68 homolog isoform X2
UPF0561 protein C2orf68 homolog isoform X1
vitamin K-dependent gamma-carboxylase-like
U4/U6.U5 tri-snRNP-associated protein 2-like
COORDINATES: nucleotide motif:Rfam:12.0:RF00004
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 52 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
transcriptional activator protein Pur-beta-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 33 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 135 Proteins, and 86% coverage of the annotated genomic feature by RNAseq alignments
PH and SEC7 domain-containing protein 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
uncharacterized LOC122543204, transcript variant X1
uncharacterized LOC122543204, transcript variant X2
uncharacterized LOC122543204, transcript variant X3
NACHT, LRR and PYD domains-containing protein 3-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
NACHT, LRR and PYD domains-containing protein 3-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
NACHT, LRR and PYD domains-containing protein 3-like, transcript variant X4
NACHT, LRR and PYD domains-containing protein 3-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
NACHT, LRR and PYD domains-containing protein 3-like, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
NACHT, LRR and PYD domains-containing protein 3-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
NACHT, LRR and PYD domains-containing protein 3-like, transcript variant X6
NACHT, LRR and PYD domains-containing protein 3-like
protein unc-93 homolog B1-like, transcript variant X2
protein unc-93 homolog B1-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
protein unc-93 homolog B1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
E3 ubiquitin-protein ligase NRDP1, transcript variant X5
E3 ubiquitin-protein ligase NRDP1, transcript variant X7
E3 ubiquitin-protein ligase NRDP1, transcript variant X6
E3 ubiquitin-protein ligase NRDP1, transcript variant X8
E3 ubiquitin-protein ligase NRDP1 isoform X3
E3 ubiquitin-protein ligase NRDP1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
E3 ubiquitin-protein ligase NRDP1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
transfer RNA serine (anticodon CGA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
E3 ubiquitin-protein ligase NRDP1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
E3 ubiquitin-protein ligase NRDP1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
unconventional myosin-Ib-like, transcript variant X2
unconventional myosin-Ib-like, transcript variant X1
unconventional myosin-Ib-like isoform X2
unconventional myosin-Ib-like isoform X1
signal transducer and activator of transcription 1-like, transcript variant X3
signal transducer and activator of transcription 1-like, transcript variant X1
signal transducer and activator of transcription 1-like, transcript variant X2
signal transducer and activator of transcription 1-like isoform X1
signal transducer and activator of transcription 1-like isoform X2
signal transducer and activator of transcription 3.1-like isoform X3
glutaminase kidney isoform, mitochondrial-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
glutaminase kidney isoform, mitochondrial-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
glutaminase liver isoform, mitochondrial-like isoform X1
glutaminase kidney isoform, mitochondrial-like isoform X2
signal transducer and activator of transcription 5B-like, transcript variant X2
signal transducer and activator of transcription 5B-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 86 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
signal transducer and activator of transcription 5B-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 86 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
signal transducer and activator of transcription 5B-like, transcript variant X1
signal transducer and activator of transcription 5B-like, transcript variant X6
signal transducer and activator of transcription 5B-like, transcript variant X3
signal transducer and activator of transcription 5B-like isoform X1
signal transducer and activator of transcription 5B-like isoform X2
NGFI-A-binding protein 2-like, transcript variant X2
NGFI-A-binding protein 2-like, transcript variant X1
NGFI-A-binding protein 2-like isoform X1
NGFI-A-binding protein 2-like isoform X2
nuclear envelope integral membrane protein 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
DnaJ (Hsp40) homolog, subfamily C, member 14, transcript variant X1
DnaJ (Hsp40) homolog, subfamily C, member 14, transcript variant X2
DnaJ (Hsp40) homolog, subfamily C, member 14, transcript variant X3
ORM1-like protein 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 51 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
ORM1-like protein 2, transcript variant X1
growth/differentiation factor 11-like, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
growth/differentiation factor 11-like, transcript variant X5
growth/differentiation factor 11-like, transcript variant X6
growth/differentiation factor 11-like, transcript variant X3
growth/differentiation factor 11-like, transcript variant X4
growth/differentiation factor 11-like, transcript variant X2
growth/differentiation factor 11-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 129 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
SAP domain containing ribonucleoprotein, transcript variant X1
SAP domain-containing ribonucleoprotein isoform X1
SAP domain containing ribonucleoprotein, transcript variant X2
SAP domain-containing ribonucleoprotein isoform X2